Initial advertised rate
$79 for the first month
Later advertised rate
$149/month
Offer condition
Three-month plan billed in full
Vial options
2.5 mL and 5 mL described
Concentration
200 mg/mL listed
Support
Provider messaging and check-ins advertised

The first price is not the continuing price

AgelessRx's injection page leads with a $79 monthly starting figure, but its offer details identify that as a first-month price for a three-month plan, followed by $149 per month. A comparison that simply lists AgelessRx at $79 indefinitely would therefore misstate the offer. We preserve the promotional condition wherever this entry appears.

The page also says the three-month plan is billed in full. Before paying, confirm the exact initial invoice and subsequent invoice schedule. A first-month rate and a prepaid plan can coexist, but neither phrase alone specifies the amount collected at enrollment.

Quantity makes this more than a headline review

The product information describes a 200 mg/mL formulation and two vial sizes: 2.5 mL and 5 mL. These correspond to different total amounts and should remain separate in a written quote. We do not assume that the lowest promotion automatically covers every size, or that a larger container is the right choice for a particular prescription.

Ask which vial the clinician expects to prescribe and which price applies. The relationship between the prescribed use, the pharmacy's time limits and the container amount determines whether all purchased medication is likely to be usable.

Support and delivery in the plan

AgelessRx advertises ongoing clinician support, messaging, check-ins and free shipping. For someone comparing service packages, clarify how an adjustment is handled if the current vial has already been dispensed. Clinical flexibility does not necessarily mean an exchange of medication or a credit for an earlier shipment.

The subscription can be paused or cancelled according to the provider's description. Obtain the practical cutoff before the next order enters processing. This matters when the initial plan is purchased for multiple months, because ending future renewals and receiving a refund for the current period are different questions.

Storage affects apparent savings

The provider's injection information includes refrigeration guidance and an after-opening discard limit. The current pharmacy label and pharmacist should resolve the instructions for the actual shipment. A reader should not stretch a container's use to match an attractive monthly estimate or carry unused medication forward merely because the purchase covered a longer period.

For cost planning, record the number of containers supplied and when each can be used, rather than treating a multi-month invoice as proof that a single opened vial lasts that long. This prevents an artificially low cost estimate based on unusable leftovers.

What the evidence supports in this review

The brand describes customer-reported benefits, research activity and energy-related goals. These are not a head-to-head trial showing that its injection outperforms other providers. Survey responses can also be affected by which customers respond and what else changed during treatment.

Our practical assessment is that the listing offers helpful formulation detail but requires disciplined reading of the promotional terms. Bring a specific treatment goal to the consultation, ask how benefit and tolerability will be reassessed, and budget with the later price as well as the first invoice. Compounded NAD+ is not an FDA-approved treatment, and a subscription's convenience does not remove that evidence boundary.

Useful distinctions

  • Vial sizes and concentration are described
  • Ongoing support is included in the public description
  • Later price is disclosed in the offer details

Limitations to weigh

  • The $79 rate is introductory and conditional
  • Exact prepaid invoice needs confirmation
  • Vial size must match the quoted offer

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. AgelessRx NAD+ Injection Provider
  2. FDA: Compounding questions and answers Regulator
  3. Grant et al. 2019: Human plasma and urine metabolome during NAD+ IV infusion Clinical research